On Monday, a woman in Seattle became America’s first human subject of a novel coronavirus vaccine trial. Dan and Axios' Bob Herman dig into the vaccine development process and why a young biotech company is leading the pack.
Prisons and detention centers are environments that are uniquely susceptible to the spread of diseases. Dan digs into the challenges with Axios' Stef Kight.
